IncellDx's Corporate Minority Round

IncellDx raised a round of funding on April 30, 2012. Investors include Bio-Reference Laboratories.

InCellDx focuses on the detection and monitoring of life-threatening diseases such as cervical cancer, breast cancer, HIV/AIDs, hepatitis and organ transplant rejection. The company's technology enabl…

Articles about IncellDx's Corporate Minority Round: